1. Home
  2. REFI vs XOMA Comparison

REFI vs XOMA Comparison

Compare REFI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFI
  • XOMA
  • Stock Information
  • Founded
  • REFI 2021
  • XOMA N/A
  • Country
  • REFI United States
  • XOMA United States
  • Employees
  • REFI N/A
  • XOMA N/A
  • Industry
  • REFI Real Estate Investment Trusts
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • REFI Real Estate
  • XOMA Health Care
  • Exchange
  • REFI Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • REFI 298.7M
  • XOMA 298.3M
  • IPO Year
  • REFI 2021
  • XOMA N/A
  • Fundamental
  • Price
  • REFI $15.61
  • XOMA $27.00
  • Analyst Decision
  • REFI Buy
  • XOMA Strong Buy
  • Analyst Count
  • REFI 4
  • XOMA 2
  • Target Price
  • REFI $17.33
  • XOMA $57.00
  • AVG Volume (30 Days)
  • REFI 103.6K
  • XOMA 31.1K
  • Earning Date
  • REFI 08-07-2024
  • XOMA 08-06-2024
  • Dividend Yield
  • REFI 12.04%
  • XOMA N/A
  • EPS Growth
  • REFI 0.51
  • XOMA N/A
  • EPS
  • REFI 1.99
  • XOMA N/A
  • Revenue
  • REFI $55,477,705.00
  • XOMA $5,811,000.00
  • Revenue This Year
  • REFI $15.73
  • XOMA $349.94
  • Revenue Next Year
  • REFI $7.11
  • XOMA $28.50
  • P/E Ratio
  • REFI $7.75
  • XOMA N/A
  • Revenue Growth
  • REFI 2.73
  • XOMA 73.10
  • 52 Week Low
  • REFI $13.86
  • XOMA $13.48
  • 52 Week High
  • REFI $17.65
  • XOMA $27.36
  • Technical
  • Relative Strength Index (RSI)
  • REFI 52.93
  • XOMA 58.66
  • Support Level
  • REFI $15.17
  • XOMA $24.36
  • Resistance Level
  • REFI $15.41
  • XOMA $27.10
  • Average True Range (ATR)
  • REFI 0.25
  • XOMA 1.39
  • MACD
  • REFI 0.01
  • XOMA 0.27
  • Stochastic Oscillator
  • REFI 71.59
  • XOMA 98.09

About REFI Chicago Atlantic Real Estate Finance Inc.

Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.

About XOMA XOMA Corporation

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Share on Social Networks: